Shanghai Runda Medical Technology Co., Ltd. (SHSE:603108) entered into an agreement to acquire an additional 12% stake in Hangzhou Yidan Biotechnology Co., Ltd and 15% stake in Shanghai Ruimei Computer Technology Co., Ltd from Shanghai Runda Shenghu Investment Management Center (Limited Partnership) and Shanghai Runqi Investment Management Center (Limited Partnership) for approximately CNY 110 million on September 26, 2019. Under the terms, Hangzhou Yidan Biotechnology reported total assets worth CNY 270 million and net assets worth CNY 177 million as of June 2019. Shanghai Ruimei Computer reported total assets worth CNY 96.3 million and net assets worth CNY 78.75 million as of June 2019. The transaction has been approved at the 34th meeting of the third Directorate of Shanghai Runda on September 26, 2019. As of October 25, 2019, Hangzhou Yidan Biotechnology Co., Ltd has completed the registration modification procedures and obtained the business license issued by the Market Supervision Administration of Xihu District Hangzhou. Accordingly, Shanghai Runda Medical Technology Co., Ltd. completed the acquisition of additional 12% stake in Hangzhou Yidan Biotechnology Co., Ltd for CNY 75.84 million and post completion it hold 57% stake in Hangzhou Yidan Biotechnology Co., Ltd. Shanghai Runda Medical Technology Co., Ltd. (SHSE:603108) cancelled the acquisition of an additional 12% stake in Hangzhou Yidan Biotechnology Co., Ltd and 15% stake in Shanghai Ruimei Computer Technology Co., Ltd from Shanghai Runda Shenghu Investment Management Center (Limited Partnership) and Shanghai Runqi Investment Management Center (Limited Partnership) on September 26, 2020.